IL6 and plasma cell myeloma: Bone marrow derived IL-6 and APRIL have been shown to be major environmental-derived factors supporting the growth and drug-resistance of multiple myeloma, and also to support the survival of long-lived bone marrow plasma cells [15], [17], [23], [39].